Apoorvi相关文献与解析，生知库 | 链接生命科学的每一步

Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast Cancers

克服黑色素瘤、头颈癌和三阴性乳腺癌免疫检查点抑制剂耐药性的机制和治疗策略

doi:10.33696/immunology.7.235

Voloshyna, Iryna; Tyagi, Apoorvi; Idga, Stanzin; Wang, Nicole; Amin, Tazrif; Hanna, Madonna; Mukhtar, Adil; Torres, Francesca; Kabir, Farah; Florian, Dominic; Wang, Chloe; Patskovsky, Yury; Krogsgaard, Michelle

The B7:CD28 family and friends: Unraveling coinhibitory interactions

B7:CD28家族及其相关基因：揭示共抑制相互作用

期刊:Immunity

影响因子:26.3

doi:10.1016/j.immuni.2024.01.013

Burke, Kelly P; Chaudhri, Apoorvi; Freeman, Gordon J; Sharpe, Arlene H

USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells

USP28 通过去泛素化癌细胞中的 MAST1 蛋白促进肿瘤发生和顺铂耐药性

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-024-05187-2

Janardhan Keshav Karapurkar #, Jencia Carminha Colaco #, Bharathi Suresh #, Apoorvi Tyagi, Sang Hyeon Woo, Won-Jun Jo, Nare Ko, Vijai Singh, Seok-Ho Hong, Seung Jun Oh, Kye-Seong Kim, Suresh Ramakrishna

USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression

USP19 负向调控 p53 并促进宫颈癌进展

期刊:Molecular Biotechnology

影响因子:2.4

doi:10.1007/s12033-023-00814-y

Apoorvi Tyagi, Janardhan Keshav Karapurkar, Jencia Carminha Colaco, Neha Sarodaya, Ainsley Mike Antao, Kamini Kaushal, Saba Haq, Arun Pandian Chandrasekaran, Soumyadip Das, Vijai Singh, Seok-Ho Hong, Bharathi Suresh, Kye-Seong Kim, Suresh Ramakrishna

Phosphopeptide Neoantigens as Emerging Targets in Cancer Immunotherapy

磷酸肽新抗原作为癌症免疫治疗的新兴靶点

期刊:

影响因子:

doi:10.33696/cancerimmunol.6.094

Apoorvi, Tyagi; Yury, Patskovsky; Iryna, Voloshyna; Michelle, Krogsgaard

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

CX3CL1-CX3CR1趋化因子轴可促进肿瘤免疫逃逸，而使用新型CX3CR1单克隆抗体阻断该轴可增强抗PD-1免疫疗法的疗效。

期刊:Frontiers in Immunology

影响因子:5.7

doi:10.3389/fimmu.2023.1237715

Apoorvi Chaudhri ，Xia Bu ，Yunfei Wang ，Michael Gomez ，James A Torchia ，Ping Hua ，Shao-Hsi Hung ，Michael A Davies ，Gregory A Lizee ，Ulrich von Andrian ，Patrick Hwu ，Gordon J Freeman

Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity

去泛素化酶USP19增强苯丙氨酸羟化酶蛋白稳定性及其酶活性

期刊:Cell Biology and Toxicology

影响因子:5.3

doi:10.1007/s10565-022-09719-z

Neha Sarodaya #, Apoorvi Tyagi #, Hyun-Jin Kim, Jencia Carminha Colaco, Ju-Seop Kang, Woo Jin Kim, Kye-Seong Kim, Suresh Ramakrishna

表观遗传

发表日期：2023

文献求助收藏

Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis

去泛素化酶亚家族的全基因组筛选确定泛素特异性蛋白酶 49 是牙本质发生的新型调节剂

期刊:Cell Death and Differentiation

影响因子:13.7

doi:10.1038/s41418-022-00956-7

Kamini Kaushal #, Eun-Jung Kim #, Apoorvi Tyagi #, Janardhan Keshav Karapurkar, Saba Haq, Han-Sung Jung, Kye-Seong Kim, Suresh Ramakrishna

CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells

基于 CRISPR/Cas9 的去泛素化酶亚家族全基因组筛选鉴定出 USP1 调控癌细胞中 MAST1 驱动的顺铂耐药性

期刊:Theranostics

影响因子:12.4

doi:10.7150/thno.72826

Apoorvi Tyagi, Kamini Kaushal, Arun Pandian Chandrasekaran, Neha Sarodaya, Soumyadip Das, Chang-Hwan Park, Seok-Ho Hong, Kye-Seong Kim, Suresh Ramakrishna

Development & validation of a format for reporting endoscopic colonic biopsies

内镜结肠活检报告格式的开发与验证

Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Melanoma, Head and Neck, and Triple-Negative Breast Cancers

克服黑色素瘤、头颈癌和三阴性乳腺癌免疫检查点抑制剂耐药性的机制和治疗策略

The B7:CD28 family and friends: Unraveling coinhibitory interactions

B7:CD28家族及其相关基因：揭示共抑制相互作用

USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells

USP28 通过去泛素化癌细胞中的 MAST1 蛋白促进肿瘤发生和顺铂耐药性

USP19 Negatively Regulates p53 and Promotes Cervical Cancer Progression

USP19 负向调控 p53 并促进宫颈癌进展

Phosphopeptide Neoantigens as Emerging Targets in Cancer Immunotherapy

磷酸肽新抗原作为癌症免疫治疗的新兴靶点

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy

CX3CL1-CX3CR1趋化因子轴可促进肿瘤免疫逃逸，而使用新型CX3CR1单克隆抗体阻断该轴可增强抗PD-1免疫疗法的疗效。

Deubiquitinase USP19 enhances phenylalanine hydroxylase protein stability and its enzymatic activity

去泛素化酶USP19增强苯丙氨酸羟化酶蛋白稳定性及其酶活性

Genome-wide screening for deubiquitinase subfamily identifies ubiquitin-specific protease 49 as a novel regulator of odontogenesis

去泛素化酶亚家族的全基因组筛选确定泛素特异性蛋白酶 49 是牙本质发生的新型调节剂

CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells

基于 CRISPR/Cas9 的去泛素化酶亚家族全基因组筛选鉴定出 USP1 调控癌细胞中 MAST1 驱动的顺铂耐药性